Blood Cancer United

From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.

Patients with blood cancers are facing unprecedented challenges to their treatment journeys as the COVID-19 pandemic continues to disrupt the cancer landscape. Which is why the Leukemia and Lymphoma Society is looking to offer its own lifeline to patients.

Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).

An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.

Many patients with blood cancers may be candidates for autologous or allogeneic transplant.